Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-25-004512
Filing Date
2025-06-16
Accepted
2025-06-16 16:15:24
Documents
74
Period of Report
2025-04-30

Document Format Files

Seq Description Document Type Size
1 10-Q zeoscientifix_10q.htm   iXBRL 10-Q 692759
2 EXHIBIT 31.1 zeoscientifix_ex31-1.htm EX-31.1 12715
3 EXHIBIT 32.1 zeoscientifix_ex32-1.htm EX-32.1 4701
  Complete submission text file 0001829126-25-004512.txt   4359181

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE zeox-20250430.xsd EX-101.SCH 46108
5 XBRL CALCULATION FILE zeox-20250430_cal.xml EX-101.CAL 48933
6 XBRL DEFINITION FILE zeox-20250430_def.xml EX-101.DEF 177603
7 XBRL LABEL FILE zeox-20250430_lab.xml EX-101.LAB 312876
8 XBRL PRESENTATION FILE zeox-20250430_pre.xml EX-101.PRE 296948
77 EXTRACTED XBRL INSTANCE DOCUMENT zeoscientifix_10q_htm.xml XML 545949
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Zeo ScientifiX, Inc. (Filer) CIK: 0001557376 (see all company filings)

EIN.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-55008 | Film No.: 251050260
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)